2019
DOI: 10.1002/mar.21209
|View full text |Cite
|
Sign up to set email alerts
|

Market claims and efficacy information in direct‐to‐consumer prescription drug print advertisements

Abstract: This study examined the impact of “New” and “#1 Prescribed” market claims and quantitative efficacy information on perceptions of a hypothetical prescription drug in a direct‐to‐consumer (DTC) print advertisement. We examined two market claims (New and #1 Prescribed), two efficacy levels (higher and lower), and a control condition without this information. Participants with diabetes were randomized to review one ad version and asked their perceptions of the ad's message, the drug's benefits, side effects and r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Because of the expansion of healthcare and better access to information about diseases and treatments, patients are taking a more active role in making their own healthcare decisions. 31 Patients' clear and complete understanding of the benefits and risks of a treatment is an essential component in facilitating effective communication between care providers, regulators, and patients. Although the FDA maintains that prescribers are the intended audience for PIs, prescribers need access to in a manner that is consistent, informative, and comprehensible; the information should be simple and clear enough to convey the intended message 32,33 to enable shared decision making, a process by which the patient and clinician work together to determine what is for the patient.…”
Section: Patient Engagement and Prosmentioning
confidence: 99%
“…Because of the expansion of healthcare and better access to information about diseases and treatments, patients are taking a more active role in making their own healthcare decisions. 31 Patients' clear and complete understanding of the benefits and risks of a treatment is an essential component in facilitating effective communication between care providers, regulators, and patients. Although the FDA maintains that prescribers are the intended audience for PIs, prescribers need access to in a manner that is consistent, informative, and comprehensible; the information should be simple and clear enough to convey the intended message 32,33 to enable shared decision making, a process by which the patient and clinician work together to determine what is for the patient.…”
Section: Patient Engagement and Prosmentioning
confidence: 99%
“…Many studies have analyzed how numeracy affects decision‐making in personal health matters (e.g., Aikin, Betts, Kaisler, & Schaefer, ; Garcia‐Retamero, Cokely, & Hoffrage, ) and financial matters (e.g., Estrada‐Mejia, de Vries, & Zeelenberg, ; Traczyk et al, ). However, there is a gap in the literature dealing with other spheres of decision‐making in which numerical information‐processing is also highly relevant, such as the tourism field.…”
Section: Introductionmentioning
confidence: 99%
“…Vigilance thus diminishes the cognitive resources needed to overcome numerosity effects. This is where policy is needed as appropriate labeling can clearly communicate nutritional information in a way to improve health outcomes (Aikin et al, 2019). Reviewing the relative prevalence of diet-sensitive illnesses and in the knowledge of the preferred consumption levels of relevant nutrients, we can select units that facilitate beneficial consumer judgments by making use of their natural biases arising from this numerosity effect.…”
Section: Discussionmentioning
confidence: 99%